|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.54 RUB | +1.43% |
|
-.--% | -.--% |
| 04-26 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Artgen Biotech PJSC reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was RUB 1,368.55 million compared to RUB 1,136.9 million a year ago. Net income was RUB 168.86 million compared to RUB 46.12 million a year ago.
Basic earnings per share from continuing operations was RUB 1.82 compared to RUB 0.53 a year ago. Diluted earnings per share from continuing operations was RUB 1.82 compared to RUB 0.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 48.52M | |
| +20.02% | 85.64B | |
| -26.96% | 70.63B | |
| +4.65% | 27.05B | |
| -5.64% | 17.97B | |
| +1.60% | 17.58B | |
| +3.21% | 15.64B | |
| +7.55% | 13.55B | |
| +9.91% | 13.41B | |
| +72.07% | 13.18B |
HUMAN STEM CELLS INSTITUTE 
